DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ advanced 2.63% to $254.87 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 2.35% to 7,549.94 and the Dow Jones Industrial Average rising 2.15% to 52,389.75.
This was the stock's second consecutive day of gains.
Biogen Inc. closed 1.51% below its 52-week high of $258.78, which the company achieved on October 28th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 2.13% to $282.11, Pfizer Inc. $(PFE)$ fell 0.54% to $29.23, and AbbVie Inc. $(ABBV)$ rose 0.68% to $293.30.
Trading volume (1.1 M) remained 16,496 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 9, 2026.
Comments